Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

45.28USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$45.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
876,860
52-wk High
$54.25
52-wk Low
$34.28

ALKS.O

Chart for ALKS.O

About

Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. The Company manufactures... (more)

Overall

Beta: 1.13
Market Cap (Mil.): $6,603.09
Shares Outstanding (Mil.): 145.83
Dividend: --
Yield (%): --

Financials

  ALKS.O Industry Sector
P/E (TTM): -- 154.10 33.86
EPS (TTM): -0.07 -- --
ROI: -0.65 -1.61 17.53
ROE: -0.88 -6.70 18.34
Search Stocks

Even with Irish address, Alkermes prefers independence

SAN DIEGO - Dublin, Ireland-based Alkermes Plc has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought out as it nears the launch of new drugs, its chief executive said on Monday.

23 Jun 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks